ALNYLAM PHARMACE.DL-,0001 financial statements, including revenue, expenses, profit, and loss
The total revenue of DUL for the last quarter is 398.39 M EUR, and it's 43.89% lower compared to the previous quarter. The net income of Q4 23 is -124.91 M EUR.